. To employ NAbs as biomarkers, an
evaluation of changes over the course of a
treatment is required
FENG, C.,
GONG, R.,
ZHENG, Q.Y.,
YANG, G.G.,
HE, M.Y.,
LEI, H.,
LI, X.D.,
ZHANG, L.,
XU, Z.H.,
LIU, S.Z.,
YU, M.X.,
MA, T.S.,
GAO, M.Q.,
BAMBA, D.,
IDIYATULLINA, E.T.,
ZAGIDULLIN, N.SH.,
PAVLOV, V.N.,
XU, C.Q.,
YUAN, Y.,
YANG, L. (2019) anti-tumor
effects of combined
treatments of ATO and blue LED on human OS cells, which were associated
neurofibromas. Therefore, long-term administration of ketotiphen was proposed for
treatment of NF1 patients